Viewing Study NCT00843050


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-02-21 @ 1:36 AM
Study NCT ID: NCT00843050
Status: TERMINATED
Last Update Posted: 2012-07-27
First Post: 2009-02-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
Sponsor: Piramal Enterprises Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mantle Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CKD inhibitor View
None Mantle Cell Lymphoma View